Maureen Lubas
Gerontology · Media, PANPI 1083084040
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,795 and has fallen 66.5% since, to $935 in 2025. Among gerontology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $84.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$911
- AbbVie$762
- AstraZeneca$724
- Novo Nordisk$526
- Otsuka America Pharmaceutical, Inc.$454
- Phathom Pharmaceuticals, Inc.$365
- plus $3K from 25 others
What the payments were for
- Food & beverage$7,233100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $911 |
| AbbVie | 7 | $762 |
| AstraZeneca | 7 | $724 |
| Novo Nordisk | 6 | $526 |
| Otsuka America Pharmaceutical, Inc. | 6 | $454 |
| Phathom Pharmaceuticals, Inc. | 4 | $365 |
| Lilly USA, LLC | 4 | $352 |
| Teva Pharmaceuticals USA, Inc. | 3 | $342 |
| GSK | 3 | $289 |
| Neurocrine Biosciences, Inc. | 2 | $253 |
| Idorsia Pharmaceuticals US Inc | 2 | $227 |
| Pfizer | 2 | $217 |
| Acadia Pharmaceuticals Inc | 10 | $180 |
| Gilead | 1 | $128 |
| Jazz Pharmaceuticals Inc. | 1 | $125 |
| CSL Behring | 1 | $124 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Sage Therapeutics, LLC | 1 | $119 |
| Heartflow, Inc. | 1 | $117 |
| Inspire Medical Systems, Inc. | 1 | $113 |
| Esperion Therapeutics, Inc. | 1 | $106 |
| Amgen | 1 | $102 |
| Neurelis, Inc. | 1 | $101 |
| Cipher Pharmaceuticals US LLC | 1 | $99 |
| Kyowa Kirin, Inc. | 1 | $87 |
| Genentech USA, Inc. | 1 | $77 |
| Insmed, Inc. | 1 | $76 |
| Urovant Sciences Inc | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Argenx US, Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,233 in reported general payments places this provider in the 95th percentile of 383 gerontology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 110 | $100,415 |
| XareltoRivaroxaban | 23 | $15,199 |
| JardianceEmpagliflozin | 24 | $13,977 |
| EntrestoSacubitril/Valsartan | 12 | $7,509 |
| OxycontinOxycodone Hcl | 17 | $5,977 |
| Rosuvastatin Calcium | 53 | $2,785 |
| Dexlansoprazole DrDexlansoprazole | 14 | $2,484 |
| Gabapentin | 150 | $2,140 |
| Atorvastatin Calcium | 163 | $1,890 |
| Levothyroxine Sodium | 141 | $1,887 |
| Potassium Chloride | 53 | $1,231 |
| Mirtazapine | 61 | $976 |
| Metoprolol Succinate | 68 | $969 |
| Famotidine | 59 | $708 |
| Escitalopram Oxalate | 57 | $691 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $217 | $100,415110 claims |
| Johnson & JohnsonXarelto | $911 | $15,19923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 383 gerontology providers in Pennsylvania.
Other gerontology in Media
- Susan ScanlandScranton$517K
- Michelle BalbiAllentown$257K
- Melissa CallahanEphrata$76K
- Maria BonanniPhiladelphia$36K
- Lisa DevaneyWest Chester$27K
- Lora DillingerWyomissing$21K
- Laken KuntzMonroeville$14K
- Kelly ShearerPittsburgh$12K
- Alanna MillerPhiladelphia$9K
- Mary KelleyPhiladelphia$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.